High-Grade Inflammation Attenuates Chemosensitivity and Confers to Poor Survival of Surgical Stage III CRC Patients
Background: Heterogeneous clinical and molecular characteristics are reported in colorectal cancer (CRC) with different tumor laterality. However, the outcome of left- and right-sided patients with stage I–III CRC and the role of chronic inflammation in survival differences between them remain uncle...
Main Authors: | Hou-Qun Ying, Xia-Hong You, Yu-Cui Liao, Fan Sun, Xue-Xin Cheng |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-04-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.580455/full |
Similar Items
-
Preoperative circulating FPR and CCF score are promising biomarkers for predicting clinical outcome of stage II–III colorectal cancer patients
by: Sun F, et al.
Published: (2018-07-01) -
Research Progress of Preoperative FPR, FAR or AFR in Patients with Colorectal Cancer
by: Chen C, et al.
Published: (2021-02-01) -
Identification of chemosensitizing agents of colorectal cancer in Rauvolfia vomitoria using an NMR-based chemometric approach
by: Wei-Liang Cui, et al.
Published: (2023-01-01) -
NGFR Increases the Chemosensitivity of Colorectal Cancer Cells by Enhancing the Apoptotic and Autophagic Effects of 5-fluorouracil via the Activation of S100A9
by: Hao Chen, et al.
Published: (2021-04-01) -
Ascorbic Acid Chemosensitizes Colorectal Cancer Cells and Synergistically Inhibits Tumor Growth
by: Ana S. Pires, et al.
Published: (2018-07-01)